Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Todt

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2024
Modeling extrahepatic hepatitis E virus infection in induced human primary neuronsMichelle Jagst, André Gömer, Sanja Augustyniak, et al.
Virus Research|May 3, 2022
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trialToni Luise Meister, Josef-Maximilian Gottsauner, Barbara Schmidt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2021
Hepatitis E: An update on One Health and clinical medicineThirumalaisamy P Velavan, Srinivas R Pallerla, Reimar Johne, et al.
Journal of Medical Virology|June 12, 2024
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patientsMathias Schemmerer, Hans H Bock, Jörn M Schattenberg, et al.
Journal of Hepatology|February 16, 2019
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitorsDominic H Banda, Paula M Perin, Richard J P Brown, et al.
The Journal of General Virology|July 28, 2016
Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horsesTheresa Gather, Stephanie Walter, Daniel Todt, et al.
Antiviral Research|January 8, 2017
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapyTanvi Khera, Daniel Todt, Koen Vercauteren, et al.
Pathogens (Basel, Switzerland)|October 23, 2020
Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global HealthSrinivas Reddy Pallerla, Dominik Harms, Reimar Johne, et al.
Microbiology Spectrum|November 27, 2023
Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungsOla Bagato, Anne Balkema-Buschmann, Daniel Todt, et al.
Hepatology Communications|November 19, 2024
The tyrosine kinase Yes1 is a druggable host factor of HEVJil Alexandra Haase, Abarna Baheerathan, Xin Zhang, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2024
Modeling extrahepatic hepatitis E virus infection in induced human primary neuronsMichelle Jagst, André Gömer, Sanja Augustyniak, et al.
Virus Research|May 3, 2022
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trialToni Luise Meister, Josef-Maximilian Gottsauner, Barbara Schmidt, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 7, 2021
Hepatitis E: An update on One Health and clinical medicineThirumalaisamy P Velavan, Srinivas R Pallerla, Reimar Johne, et al.
Journal of Medical Virology|June 12, 2024
Proof of infectivity of hepatitis E virus particles from the ejaculate of chronically infected patientsMathias Schemmerer, Hans H Bock, Jörn M Schattenberg, et al.
Journal of Hepatology|February 16, 2019
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitorsDominic H Banda, Paula M Perin, Richard J P Brown, et al.
The Journal of General Virology|July 28, 2016
Vertical transmission of hepatitis C virus-like non-primate hepacivirus in horsesTheresa Gather, Stephanie Walter, Daniel Todt, et al.
Antiviral Research|January 8, 2017
Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapyTanvi Khera, Daniel Todt, Koen Vercauteren, et al.
Pathogens (Basel, Switzerland)|October 23, 2020
Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global HealthSrinivas Reddy Pallerla, Dominik Harms, Reimar Johne, et al.
Microbiology Spectrum|November 27, 2023
Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungsOla Bagato, Anne Balkema-Buschmann, Daniel Todt, et al.
Hepatology Communications|November 19, 2024
The tyrosine kinase Yes1 is a druggable host factor of HEVJil Alexandra Haase, Abarna Baheerathan, Xin Zhang, et al.
Pageof 16